Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense company, has announced a major scientific ...
Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.
Rocket Pharmaceuticals advances gene therapies for rare diseases. Momentum aligns with broader biotech trends in the Nasdaq ...
Lentiviral vectors effectively deliver the gene that encodes coagulation factor IX (FIX) to the liver in dogs with naturally occurring hemophilia B (factor IX deficiency), researchers report in an ...
NexCAR19, the world’s first humanised CAR-T therapy developed in India, has made gene therapies affordable and accessible ...
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I(TM)), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the ...
Lentiviral vectors have emerged as indispensable tools in gene therapy, offering the ability to integrate therapeutic genes into both dividing and non-dividing cells. Their unique capacity to achieve ...
Contract development and manufacturing organization (CDMO) Matica Biotechnology has partnered with Calidi Biotherapeutics to advance and manufacture CLD-401, a tumor-tropic oncolytic virus designed to ...
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best NASDAQ stocks under $5 to buy now. On October 14, Rocket ...
In this GEN webinar, LV expert Brianna Jayanthi, PhD, will discuss how Asimov's LV Edge Producer and Packaging Systems are leading to higher-quality, higher-productivity cell lines to support clinical ...
Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback